CAI – caris life sciences, inc. (US:NASDAQ)
Stock Stats
News
Caris Life Sciences Announces Launch of Caris ChromoSeq, the World's First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid Malignancies [Yahoo! Finance]
Caris Life Sciences Announces Launch of Caris ChromoSeq, the World's First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid Malignancies [TheStreet.com]
Caris Life Sciences Announces Launch of Caris ChromoSeq, the World's First Whole Genome and Whole Transcriptome Tumor Profiling Assay for Myeloid Malignancies
Caris Life Sciences (CAI) is now covered by The Goldman Sachs Group, Inc.. They set a "buy" rating and a $27.00 price target on the stock.
Caris Life Sciences Finalizes Achieve 1 Study Results Reinforcing the Superior Sensitivity and Specificity of Caris Detect [Yahoo! Finance]
Form 8-K Caris Life Sciences, For: Apr 01
Form 4 Caris Life Sciences, For: Mar 06 Filed by: Power Luke Thomas
Form 4 Caris Life Sciences, For: Mar 06 Filed by: Denton John Russel
Form 4 Caris Life Sciences, For: Mar 06 Filed by: Spetzler David Baxley
Form 4 Caris Life Sciences, For: Mar 06 Filed by: Brille Brian J
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.